Abstract
We have recently reported a novel function for carbonyl reductase (CR), namely, its ability to modulate the metastatic potential of malignant mouse cells. Because there are currently no data addressing a similar function for CR in human cancers, the aim of this study was to assess a correlation between survival and metastasis, and CR level in epithelial ovarian cancer. Using anti-CR antibody, immunohistochemical staining was performed on 73 epithelial ovarian cancers, 13 borderline malignant tumours, and 25 benign ovarian tumours for a total of 111 specimens. The combined rate for strongly and weakly positive reactions for CR was 32.0% for benign tumours, 38.5% for borderline malignant tumours, and 61.6% for ovarian cancers. The CR-positive rate was 35.7% (weakly positive alone) for ovarian cancers with retroperitoneal lymph node (RLN) metastasis and 67.8% for those without RLN metastasis (P< 0.05). The 5-year survival rate was 62.7% for the patients with CR-negative cancer and 86.1% for those with CR-positive cancer (P< 0.05). The present results indicate that decreased CR expression in epithelial ovarian cancer is associated with RLN metastasis and poor survival. © 2001 Cancer Research Campaign http://www.bjcancer.com
Similar content being viewed by others
Article PDF
Change history
16 November 2011
This paper was modified 12 months after initial publication to switch to Creative Commons licence terms, as noted at publication
References
Ablin RJ and Shaw MW (1986) Prostaglandin modulation of prostate tumor growth and metastases. Anticancer Res 6: 327–328
Ahmed NK, Felsted RL and Bachur NR (1978) Heterogeneity of anthracycline antibiotics carbonyl reductases in mammalian livers. Biochem Pharmacol 27: 2713–2719
Chambers SK, Kacinski BM, Ivins CM and Carcangiu ML (1997) Overexpression of epithelial macrophage colony-stimulating factor (CSF-1) and CSF-1 receptor: a poor prognostic factor in epithelial ovarian cancer, contrasted with a protective effect of stromal CSF-1. Clin Cancer Res 6: 999–1007
Ismail E, Al-Mulla F, Tsuchida S, Suto K, Motley P, Harrison PR and Birnie GD (2000) Carbonyl reductase: a novel metastasis modulating function. Cancer Res 60: 1173–1176
Iwata N, Inazu N and Satoh T (1990) Immunological and enzymological localization of carbonyl reductase in ovary and liver of various species. J Biochem 107: 209–212
Kajihara-Kano H, Hayakari M, Satoh K, Tomioka Y, Mizugaki M and Tsuchida S (1997) Characterization of S-hexylglutathione binding proteins of human hepatocellular carcinoma: separation of enoyl-CoA isomerase from an alpha class glutathione transferase form. Biochem J 328: 473–478
Kuffel MJ, Reid JM and Ames MM (1992) Anthracyclines and their C-13 alcohol metabolites: growth inhibition and DNA damage following incubation with human tumor cells in culture. Cancer Chemother Pharmacol 30: 51–57
Lee SC and Levine L (1974) Prostaglandin metabolism I. Cytoplasmic reduced nicotinamide adenine dinucleotide phosphate-dependent and microsomal reduced nicotinamide adenine dinucleotide-dependent prostaglandin E9-ketoreductase activities in monkey and pigeon tissues. J Biol Chem 249: 1369–1375
Lopez de Cerain A, Marin A, Idoate MA, Tunon MT and Bello J (1999) Carbonyl reductase and NADPH cytochrome P450 reductase activity in human tumoral versus normal tissues. Eur J Cancer 35: 32–34
Schieber A, Frank RW and Ghisla S (1992) Purification and properties of prostaglandin 9-ketoreductase from pig and human kidney: Identity with human carbonyl reductase. Eur J Biochem 206: 491–502
Sheng H, Shao J, Morrow JD, Beauchamp RD and DuBois RN (1998) Modulation of apoptosis and bcl-2 expression by prostaglandin E2in human colon cancer cells. Cancer Res 58: 362–366
Silverberg SG (1999) Molecular diagnosis and prognosis in gynecologic oncology. Arch Pathol Lab Med 123: 1035–1040
Suto K, Kajihara-Kano H, Yokoyama Y, Hayakari M, Kimura J, Kumano T, Takahata T, Kudo H and Tsuchida S (1999) Descreased expression of the peroxisomal bifunctional enzyme and carbonyl reductase in human hepatocellular carcinomas. J Cancer Res Clin Oncol 125: 83–88
Tempfer C, Obermair A, Hefler L, Haeusler G, Gitsch G and Kainz C (1998) Vascular endothelial growth factor serum concentrations in ovarian cancer. Obstet Gynecol 92: 360–363
Tsujii M, Kawano S, Tsuji S, Sawaoka H, Hori M and DuBois RN (1998) Cyclooxygenase regulates angiogenesis induced by colon cancer cells. Cell 93: 705–716
Wermuth B (1981) Purification and properties of an NADPH-dependent carbonyl reductase from human brain. Relationship to prostaglandin 9-ketoreductase and xenobiotic ketone reductase. J Biol Chem 256: 1206–1213
Wermuth B, Bohren KM, Heinemann G, Von Warthburg JP and Gabbay KH (1988) Human carbonyl reductase. Nucleotide sequence analysis of a cDNA and amino acid sequence of the encoded protein. J Biol Chem 263: 16185–16188
Werness BA, Freedman AN, Piver MS, Romero-Gutierrez M and Petrow E (1999) Prognostic significance of p53 and p21waf1/cip1immunoreactivity in epithelial cancers of the ovary. Gynecol Oncol 75: 413–418
Yokoyama Y, Sakamoto T, Sato S and Saito Y (1999) Evaluation of cytoreductive surgery with pelvic and paraaortic lymphadenectomy and intermittent cisplatin-based combination chemotherapy for improvement of long-term survival in ovarian cancer. Eur J Gynaecol Oncol 20: 361–366
Yokoyama Y, Sato S, Futagami M, Fukushi Y, Sakamoto T, Umemoto M and Saito Y (2000) Prognostic significance of vascular endothelial growth factor and its receptors in endometrial carcinoma. Gynecol Oncol 77: 413–418
Author information
Authors and Affiliations
Rights and permissions
From twelve months after its original publication, this work is licensed under the Creative Commons Attribution-NonCommercial-Share Alike 3.0 Unported License. To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-sa/3.0/
About this article
Cite this article
Umemoto, M., Yokoyama, Y., Sato, S. et al. Carbonyl reductase as a significant predictor of survival and lymph node metastasis in epithelial ovarian cancer. Br J Cancer 85, 1032–1036 (2001). https://doi.org/10.1054/bjoc.2001.2034
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1054/bjoc.2001.2034
Keywords
This article is cited by
-
Development of transgenic mice overexpressing mouse carbonyl reductase 1
Molecular Biology Reports (2023)
-
Methylation Mediated Downregulation of TOB1-AS1 and TOB1 Correlates with Malignant Progression and Poor Prognosis of Esophageal Squamous Cell Carcinoma
Digestive Diseases and Sciences (2023)
-
Aberrant methylation-mediated downregulation of lncRNA SSTR5-AS1 promotes progression and metastasis of laryngeal squamous cell carcinoma
Epigenetics & Chromatin (2019)
-
Inhibitory effect of carbonyl reductase 1 against peritoneal progression of ovarian cancer: evaluation by ex vivo 3D-human peritoneal model
Molecular Biology Reports (2019)
-
Promoter hypermethylation-mediated downregulation of tumor suppressor gene SEMA3B and lncRNA SEMA3B-AS1 correlates with progression and prognosis of esophageal squamous cell carcinoma
Clinical & Experimental Metastasis (2019)